ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
<em>The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1-11 years (10 or 20 mg daily) and 12-17 years (20 or 40 mg daily) with gerd according...
Spremljeno u:
Glavni autor: | |
---|---|
Format: | Knjiga |
Izdano: |
"Paediatrician" Publishers LLC,
2008-01-01T00:00:00Z.
|
Teme: | |
Online pristup: | Connect to this object online. |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Primjerak 1 | Dostupno |